Structure and Content of a Taxonomy to Support the Use of Real-World Evidence by Health Technology Assessment Practitioners and Healthcare Decision Makers
- 24 January 2023
- journal article
- research article
- Published by Elsevier BV in Value in Health
- Vol. 26 (4), 20-31
- https://doi.org/10.1016/j.jval.2023.01.007
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Real-world evidence for coverage decisions: opportunities and challengesJournal of Comparative Effectiveness Research, 2018
- A framework to guide the optimal development and use of real-world evidence for drug coverage and formulary decisionsJournal of Comparative Effectiveness Research, 2018
- A review and validation of overall survival extrapolation in health technology assessments of cancer immunotherapy by the National Institute for Health and Care Excellence: how did the initial best estimate compare to trial data subsequently made available?Journal of Medical Economics, 2018
- A review of NICE appraisals of pharmaceuticals 2000–2016 found variation in establishing comparative clinical effectivenessJournal of Clinical Epidemiology, 2018
- Real-World Data Analytics Fit for Regulatory Decision-MakingAmerican Journal of Law & Medicine, 2018
- Managing Missing Data in Patient RegistriesPublished by Agency for Healthcare Research and Quality ,2018
- The effectiveness of varenicline versus nicotine replacement therapy on long-term smoking cessation in primary care: a prospective cohort study of electronic medical recordsInternational Journal of Epidemiology, 2017
- Comparing the Effectiveness of Dynamic Treatment Strategies Using Electronic Health Records: An Application of the Parametric g‐Formula to Anemia Management StrategiesHealth Services Research, 2017
- Analytical Methods for a Learning Health System: 3. Analysis of Observational StudieseGEMs (Generating Evidence & Methods to improve patient outcomes), 2017
- Complete Cytogenetic Response and Major Molecular Response as Surrogate Outcomes for Overall Survival in First-Line Treatment of Chronic Myelogenous Leukemia: A Case Study for Technology Appraisal on the Basis of Surrogate Outcomes EvidenceValue in Health, 2013